CTOs on the Move


 
Inari embraces diversity in every aspect of our business to drive innovation and help build a new food system. Our technology matches the complexity of nature to transform seed using predictive design and multiplex gene editing – unlocking the full potential through our SEEDesign™ platform. The result is step-change products that lead to more productive acres and a more sustainable future for the food system.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.inari.com
  • One Kendall Square Building 600/700 Suite 7-501
    Cambridge, MA USA 02139
  • Phone: 774.489.5343

Executives

Name Title Contact Details
Rania Khalaf
Chief Information and Data Officer Profile

Funding

Inari raised $40M on 08/09/2018
Inari raised $89M on 08/01/2019
Inari raised $45M on 04/22/2020
Inari raised $208M on 05/12/2021

Similar Companies

GRAIL

GRAIL`s mission is to detect cancer early, when it can be cured.

Octant Bio

Octant is a well-backed team of experienced scientists and entrepreneurs exploring new frontiers of biology. We are applying next-generation DNA sequencing, gene synthesis, and gene editing to revolutionize drug discovery in a quest for safer, more effective, and cheaper drugs.

Tissue Gnostics

Tissue Gnostics is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Custom Biogenic Systems

Custom Biogenic Systems is a Romeo, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MAIA Biotechnology

MAIA Biotech is a targeted therapy, immuno-oncology company focused on the development and commercialization of first-in-class drugs